Triglyceride/HDL-cholesterol ratio and plasminogen activator inhibitor-1 independently predict high pulse pressure in sickle cell trait and disease

References

• Bayramoğlu, T., et al., 2013. Arterial stiffness and pulse wave reflection in young adult heterozygous sickle cell carriers. Turkish journal of haematology: official journal of Turkish society of haematology, 30 (4), 379–386.
   PubMed Web of Science ®Google Scholar
• Belizna, C., et al., 2012. Arterial stiffness and stroke in sickle cell disease. Stroke, 43 (4), 1129–1130.
   PubMed Web of Science ®Google Scholar
• Benetos, A., et al., 2010. Pulse pressure amplification a mechanical biomarker of cardiovascular risk. Journal of the American college of cardiology, 55 (10), 1032–1037.
   PubMed Web of Science ®Google Scholar
• Buchowski, M.S., et al., 2007. Defects in postabsorptive plasma homeostasis of fatty acids in sickle cell disease. Journal of parenteral and enteral nutrition, 31 (4), 263–268.
   PubMed Web of Science ®Google Scholar
• Cesari, M., Pahor, M., and Incalzi, R.A., 2010. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovascular therapeutics, 28 (5), e72–e91.
   PubMed Web of Science ®Google Scholar
• Choy, E. and Sattar, N., 2009. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Annals of the rheumatic diseases, 68 (4), 460–469.
   PubMed Web of Science ®Google Scholar
• Connes, P., et al., 2008. Blood rheology abnormalities and vascular cell adhesion mechanisms in sickle cell trait carriers during exercise. Clinical hemorheology and microcirculation, 39 (1-4), 179–184.
   PubMed Web of Science ®Google Scholar
• da-Luz, P.L., et al., 2008. High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics, 63 (4), 427–432.
   PubMed Web of Science ®Google Scholar
• Devaraj, S., Xu, D.Y., and Jialal, I., 2003. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation, 107 (3), 398–404.
   PubMed Web of Science ®Google Scholar
• Du, T., et al., 2014. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovascular diabetology, 13 (1), 146.
   PubMedGoogle Scholar
• Famodu, A.A., et al., 1998. Haemorheological changes in sickle cell disease: measurement and significance. British journal of biomedical science, 55, 265–267.
   PubMed Web of Science ®Google Scholar
• Fernandez-Fresnedo, G., et al., 2006. Role of pulse pressure on cardiovascular risk in chronic kidney disease patients. Journal of the American society of nephrology, 17 (12 suppl 3), S246–S249.
   PubMedGoogle Scholar
• Friedewald, W.T., Levy, R.I., and Fredrickson, D.S., 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clinical chemisty, 18, 499–502.
   PubMed Web of Science ®Google Scholar
• Frontini, M.G., et al., 2008. Usefulness of childhood non-high density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis: the Bogalusa Heart Study. Pediatrics, 121 (5), 924–929.
   PubMed Web of Science ®Google Scholar
• Goldberg, I.J., Eckel, R.H., and McPherson, R., 2011. Triglycerides and heart disease: still a hypothesis?. Arteriosclerosis, thrombosis, and vascular biology, 31 (8), 1716–1725.
   PubMed Web of Science ®Google Scholar
• Gordon, R.J., 1972. Viscosity considerations in the determination of regional circulatory adjustments to anemia. Circulation research, 31, 805–812.
   PubMed Web of Science ®Google Scholar
• Hillery, C.A. and Panepinto, J.A., 2004. Pathophysiology of stroke in sickle cell disease. Microcirculation (New York, N.Y.: 1994), 11 (2), 195–208.
   PubMed Web of Science ®Google Scholar
• Johnson, C.S., 2005. Arterial blood pressure and hyperviscosity in sickle cell disease. Hematology/Oncology clinics of North America, 19 (5), 827–837.
   PubMed Web of Science ®Google Scholar
• Key, N.S., Connes, P., and Derebail, V.K., 2015. Negative health implications of sickle cell trait in developed countries: from the football field to the laboratory. British journal of haematology, 170 (1), 5–14.
   PubMed Web of Science ®Google Scholar
• Lamarre, Y., et al., 2014. Relationships between systemic vascular resistance, blood rheology and nitric oxide in children with sickle cell anemia or sickle cell-hemoglobin C disease. Clinical hemorheology and microcirculation, 58 (2), 307–316.
   PubMed Web of Science ®Google Scholar
• Laurent, S., Briet, M., and Boutouyrie, P., 2009. Large and small artery cross-talk and recent morbidity mortality trials in hypertension. Hypertension, 54 (2), 388–392.
   PubMed Web of Science ®Google Scholar
• Lee, M.L., Rosner, B.A., and Weiss, S.T., 1999. Relationship of blood pressure to cardiovascular death: the effects of pulse pressure in the elderly. Annals of epidemiology, 9 (2), 101–107.
   PubMed Web of Science ®Google Scholar
• Lemaire, C., et al., 2013. Severe proliferative retinopathy is associated with blood hyperviscosity in sickle cell hemoglobin-C disease but not in sickle cell anemia. Clinical hemorheology and microcirculation, 55, 205–212.
   PubMed Web of Science ®Google Scholar
• Lieb, W., et al., 2009. A multi-marker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study. Circulation, 119 (1), 37–43.
   PubMed Web of Science ®Google Scholar
• Lira, F.S., et al., 2010. Sedentary subjects have higher PAI-1 and lipoproteins levels than highly trained athletes. Diabetology and metabolic syndrome, 2 (1), 7.
   PubMedGoogle Scholar
• Lozano, R., et al., 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England), 380 (9859), 2095–2128.
   PubMed Web of Science ®Google Scholar
• Meigs, J.B., et al., 2006. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. The journal of clinical endocrinology and metabolism, 91 (8), 2906–2912.
   PubMed Web of Science ®Google Scholar
• Mitchell, G.F., et al., 2007. Cross-sectional correlates of increased aortic stiffness in the community: the Framingham Heart Study. Circulation, 115 (20), 2628–2636.
   PubMed Web of Science ®Google Scholar
• Nishiwaki, Y., et al., 2000. Relationship between the blood coagulation-fibrinolysis system and the subclinical indicators of arteriosclerosis in a healthy male population. Journal of epidemiology, 10 (1), 34–41.
   PubMedGoogle Scholar
• Novelli, E.M., et al., 2014. Elevated pulse pressure is associated with hemolysis, proteinuria and chronic kidney disease in sickle cell disease. PLoS One, 9 (12), e114309.
   PubMed Web of Science ®Google Scholar
• Nsiri, B., et al., 1997. Fibrinolytic response to venous occlusion in patients with homozygous sickle cell disease. Hematology and cell therapy, 39 (5), 229–232.
   PubMedGoogle Scholar
• Piel, F.B., et al., 2013. Global epidemiology of sickle hemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet, 381 (9861), 142–151.
   PubMed Web of Science ®Google Scholar
• Pikilidou, M., et al., 2015. Arterial stiffness and peripheral and central blood pressure in patients with sickle cell disease. Journal of clinical hypertension, 17 (9), 726–731.
   Web of Science ®Google Scholar
• Platt, O.S., 2000. Sickle cell anemia as an inflammatory disease. The journal of clinical investigation, 106 (3), 337–338.
   PubMed Web of Science ®Google Scholar
• Rahimi, Z., et al., 2006. Plasma lipids in Iranians with sickle cell disease: hypocholesterolemia in sickle cell anemia and increase of HDL-cholesterol in sickle cell trait. Clinica chimica acta; International journal of clinical chemistry, 365 (1-2), 217–220.
   PubMed Web of Science ®Google Scholar
• Rosano, C., et al., 2013. Aortic pulse wave velocity predicts focal white matter hyperintensities in a biracial cohort of older adults. Hypertension, 61 (1), 160–165.
   PubMed Web of Science ®Google Scholar
• Safar, M.E., et al., 2013. Hypertension and vascular dynamics in men and women with metabolic syndrome. Journal of the American college of cardiology, 61 (1), 12–19.
   PubMed Web of Science ®Google Scholar
• Schnabel, R., et al., 2008. Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection. Hypertension, 51 (6), 1651–1657.
   PubMed Web of Science ®Google Scholar
• Stefansson, S. and Lawrence, D.A., 1996. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature, 383 (6599), 441–443.
   PubMed Web of Science ®Google Scholar
• Stehouwer, C.D., Henry, R.M., and Ferreira, I., 2008. Arterial stiffness in diabetes and metabolic syndrome: a pathway to cardiovascular disease. Diabetologia, 51 (4), 527–539.
   PubMed Web of Science ®Google Scholar
• Temelkova-Kurktschiev, T.S., et al., 2009. Pulse pressure is a strong predictor of cardiovascular risk: data of the risk factors in impaired glucose tolerance for artherosclerosis and diabetes and the Sofia Metabolic Syndrome studies. Folia medica (Plovdiv), 51, 34–41.
   PubMedGoogle Scholar
• Van-Popele, N.M., et al., 2000. Variables of the insulin resistance syndrome are associated with reduced arterial distensibility in healthy non-diabetic middle-aged women. Diabetologia, 43 (5), 665–672.
   PubMed Web of Science ®Google Scholar
• Wang, L., et al., 2009. Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. Journal of lipid research, 50 (2), 204–213.
   PubMed Web of Science ®Google Scholar
• Xi, B., et al., 2014. Hypertension screening using blood pressure to height ratio. Pediatrics, 134 (1), e106.
   PubMed Web of Science ®Google Scholar
• Yasmin. et al., 2004. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arteriosclerosis, thrombosis, and vascular biology, 24, 969–974.
   PubMed Web of Science ®Google Scholar
• Yasuno, S., et al., 2010. Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients? A subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial. Diabetes Care, 33 (5), 1122–1127.
   PubMed Web of Science ®Google Scholar
• Zorca, S., et al., 2010. Lipid levels in sickle-cell disease associated with hemolytic severity, vascular dysfunction, and pulmonary hypertension. British journal of haematology, 149 (3), 436–445.
   PubMed Web of Science ®Google Scholar